Optimer Pharmaceutic (OPTR), Orbitz Worldwide, Inc. (OWW), MetroPCS (PCS), GSV Capital Corp. (GSVC), Hollysys Automation Technologies Ltd (HOLI) and Henry Schein, Inc. (HSIC) ratings and price targets.
Needham & Company reiterated its “Buy” rating on Optimer Pharmaceutic (OPTR).
Benchmark Co. upgraded Orbitz Worldwide, Inc. (OWW) from a “Hold” rating to a “Buy” rating. They have a price target of $5.00 on the company, up from $3.00.
William Blair upgraded MetroPCS (PCS) from a “Market Perform” rating to an “Outperform” rating.
Ladenburg Thalmann initiated coverage on GSV Capital Corp. (GSVC). They placed a “Buy” rating and a price target of $17.25 on the company.
Citigroup (NYSE:C) initiated coverage on Hollysys Automation Technologies Ltd (HOLI). They placed a “Buy” rating on the company.
Deutsche Bank (NYSE:DB) initiated coverage on Henry Schein, Inc. (HSIC). They placed a “Hold” rating and a price target of $66.50 on the company.
No comments:
Post a Comment